Skip to Main Content

Paper Details

The selenium-containing drug ebselen potently disrupts LEDGF/p75-HIV-1 integrase interaction by targeting LEDGF/p75.
Journal of Enzyme Inhibition and Medicinal Chemistry
14
2020
2-phenyl-1,2-benzisoselenazol-3-one, DTT, Ebselen, HIV-, HIV-1, HIV-1 integrase, IN, LEDGF, LEDGF-IN, LEDGINs, Lens-epithelium-derived growth-factor, Lens-epithelium-derived growth-factor (LEDGF/p75)-binding site, dithiothreitol, ebselen, p75, p75-IN, selenium, sulphur, thiols
Author NameAffiliation
Shan ChangJiangsu University of Technology
  • 1 - 1

Datasets

Release 1.2